Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Interest Expenses: 2009-2024

Historic Interest Expenses for Lifecore Biomedical (LFCR) over the last 16 years, with May 2024 value amounting to $14.7 million.

  • Lifecore Biomedical's Interest Expenses rose 42.64% to $4.6 million in Q4 2024 from the same period last year, while for Nov 2024 it was $17.3 million, marking a year-over-year increase of 3.12%. This contributed to the annual value of $14.7 million for FY2024, which is 14.90% down from last year.
  • As of FY2024, Lifecore Biomedical's Interest Expenses stood at $14.7 million, which was down 14.90% from $17.2 million recorded in FY2023.
  • Lifecore Biomedical's Interest Expenses' 5-year high stood at $17.2 million during FY2023, with a 5-year trough of $4.6 million in FY2020.
  • Its 3-year average for Interest Expenses is $15.8 million, with a median of $15.5 million in 2022.
  • As far as peak fluctuations go, Lifecore Biomedical's Interest Expenses skyrocketed by 92.27% in 2021, and later fell by 14.90% in 2024.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Interest Expenses stood at $4.6 million in 2020, then surged by 92.27% to $8.9 million in 2021, then surged by 73.18% to $15.5 million in 2022, then increased by 11.37% to $17.2 million in 2023, then decreased by 14.90% to $14.7 million in 2024.